Cell/Gene Therapies: Regulatory Strengthening Needed To Ensure Global Confidence

 
• By Sue Sutter

Bolstering regulatory expertise in low- and middle-income countries could help prevent a safety-related disaster that chills enthusiasm for the field, while greater regulatory convergence could help tamp down the proliferation of stem cell clinics, the FDA’s Peter Marks says.

Mole hills
Like mole hills in a yard, stem cell clinics are popping up all over the world due to a lack of uniform regulatory oversight, FDA's Marks says. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies